These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26362969)

  • 1. Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractile agents.
    Benyahia C; Ozen G; Orie N; Ledwozyw A; Louedec L; Li F; Senbel AM; Silverstein A; Danel C; Longrois D; Clapp LH; Norel X; Topal G
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):46-52. PubMed ID: 26362969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
    Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
    Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary artery.
    Morrison K; Studer R; Ernst R; Haag F; Kauser K; Clozel M
    J Pharmacol Exp Ther; 2012 Dec; 343(3):547-55. PubMed ID: 22918043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries.
    Fuchikami C; Murakami K; Tajima K; Homan J; Kosugi K; Kuramoto K; Oka M; Kuwano K
    Eur J Pharmacol; 2017 Jan; 795():75-83. PubMed ID: 27919660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
    Arshad M; Vijay V; Floyd BC; Marks B; Sarabu MR; Wolin MS; Gupte SA
    Ann Thorac Surg; 2006 Jun; 81(6):2147-54. PubMed ID: 16731144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
    Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
    Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1999 May; 127(1):291-9. PubMed ID: 10369485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between PGI
    Ozen G; Benyahia C; Amgoud Y; Patel J; Abdelazeem H; Bouhadoun A; Yung S; Li F; Mahieddine Y; Silverstein AM; Castier Y; Cazes A; Longrois D; Clapp LH; Norel X
    Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106388. PubMed ID: 31672620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
    Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid (MRE-269), on rat pulmonary artery.
    Kuwano K; Hashino A; Noda K; Kosugi K; Kuwabara K
    J Pharmacol Exp Ther; 2008 Sep; 326(3):691-9. PubMed ID: 18552131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilation induced by PGE
    Ozen G; Benyahia C; Mani S; Boukais K; Silverstein AM; Bayles R; Nelsen AC; Castier Y; Danel C; Mal H; Clapp LH; Longrois D; Norel X
    Br J Pharmacol; 2020 Jan; 177(1):161-174. PubMed ID: 31476020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries.
    Piamsomboon C; Tanaka KA; Szlam F; Makita T; Huraux C; Levy JH
    Acta Anaesthesiol Scand; 2007 Jul; 51(6):714-21. PubMed ID: 17488313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxant effect of the prostacyclin analogue iloprost on isolated human radial artery: An approach for the reversal of graft spasm.
    Engin E; Alp Yildirim Fİ; Kalelі Durman D; Ömeroğlu SN; Göksedef D; Teskіn Ö; Balkanay OO; İpek G; Uydeş Doğan BS
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():35-41. PubMed ID: 29107024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoid receptor subtypes involved in treprostinil-mediated vasodilation of rat pulmonary arteries and in treprostinil-mediated inhibition of collagen gene expression of human lung fibroblasts.
    Corboz MR; Salvail W; Gagnon S; LaSala D; Laurent CE; Salvail D; Chen KJ; Cipolla D; Perkins WR; Chapman RW
    Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106486. PubMed ID: 33011365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries.
    Arner M; Högestätt ED
    Acta Physiol Scand; 1991 Jun; 142(2):165-72. PubMed ID: 1715111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vasoconstrictor effects of prostacyclin in rats: potential role of thromboxane receptors.
    Zhao YJ; Wang J; Tod ML; Rubin LJ; Yuan XJ
    J Appl Physiol (1985); 1996 Dec; 81(6):2595-603. PubMed ID: 9018511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.